The Leveraged-ETF Rotation Backtest That Turns $100k Into Billions — And Why You Can't Trade It

Open any algo-trading forum and you’ll find them: leveraged-ETF rotation “symphonies.” Daily bots that read RSI and moving averages, then flip a portfolio between TQQQ (3x Nasdaq), SOXL (3x semis), TECL (3x tech) and a basket of volatility and bond hedges. The backtests look like nothing else in finance — smooth, relentless, up-and-to-the-right curves that turn a small account into a fortune. Someone shared one with us and asked the honest question: is it worth pursuing?

So we took the exact strategy — a four-bot RSI/SMA ensemble — ported it into our backtest engine, and ran it on 13 years of real, dividend-adjusted ETF data with real costs, instead of the one year with zero slippage it shipped with. Here’s what we found, and what’s actually true.

The backtest turns $100k into $5.5 billion

That’s not a typo, and it’s not a bug. Run faithfully on real prices, the strategy compounds at about 129% per year over 2013–2026. We had to plot it on a log scale because on a linear axis buy-and-hold QQQ — which itself 10x’d — is a flat line at the bottom.

Your first instinct should be the correct one: a backtest that turns $100k into billions is a red flag, not an edge. No fund in history has compounded at triple digits for a decade. So where does the number come from — and is the strategy “good” or not?

It’s not a bug — it’s just unrealizable

We checked carefully: there’s no lookahead, no calculation error. The rules, applied to real split/dividend-adjusted prices with whole-share rebalancing and commissions, genuinely produce this. The backtest is correct. It’s just not achievable, for three concrete reasons:

• Capacity. The strategy rebalances the entire book into 3x leveraged ETFs every single day. On $100k in a simulator, fine. At any real size, you can’t get filled in TQQQ/SOXL/SVIX daily without moving the price against yourself. The edge evaporates as you scale — the strategy’s own “estimated capacity” would be tiny.
• Leveraged beta plus survivorship. TQQQ rose roughly 70x over the period. Being concentrated-long the exact leveraged ETFs that mooned, through the biggest tech bull in history, produces fantasy compounding. That’s not skill — it’s 3x exposure to a one-way market.
• Overfitting. Look at the thresholds: RSI above 79, 80, 81; a 202-day moving average (why 202?); a −12% 60-day filter. These are hand-tuned to this specific history. Forward, they don’t replicate.

And here’s the tell that it isn’t even a slippage problem: we re-ran it at progressively brutal costs.

slippage   compounding annual return   end equity
   0 bps            +150% / yr           $17.7 B
   5 bps            +143% / yr           $12.0 B
  15 bps            +129% / yr           $5.5 B
  30 bps            +110% / yr           $1.8 B
  50 bps             +83% / yr           $293 M

Even at a punishing 50 bps per trade it still “makes” 83% a year. The returns are so large that the problem isn’t the fills — it’s capacity and compounding fantasy.

Every year is absurd — and it bleeds in the off-years

Year by year, the returns aren’t just good — they’re impossible to sustain: +135%, +200%, +449% in 2020, +280% in 2022. That’s the signature of leveraged beta, not a repeatable edge. And notice the cracks: it was red in 2015 and 2018 — the years without a clean V-shaped recovery, when leverage cuts the other way.

The summary looks like a dream — until you read two lines

Sharpe 1.80, Sortino 2.51, Calmar 2.0, 12 of 14 years positive. On a metrics sheet, it looks unbeatable. Then you read End Equity: $5.5 billion and Max Drawdown: −63% and the spell breaks. A −63% drawdown is worse than simply holding QQQ (−35%), and almost nobody can sit through losing two-thirds of their account — least of all when the account is a large, leveraged number.

So is the strategy “successful”? Real, but overstated

Be fair to it: on a risk-adjusted basis it does beat buy-and-hold on paper — Sharpe 1.8 versus QQQ’s 0.95, Calmar 2.0 versus 0.5. The risk-on/risk-off rotation genuinely improved drawdown-per-unit-of-return compared with just holding 3x. That part isn’t nothing.

But the “success” is mostly leveraged tech beta in a historic bull, plus hindsight hedges — the volatility and managed-futures positions were added precisely because they would have helped in 2020 and 2022. It’s never been tested in a regime it wasn’t built on. The honest forward expectation is a small fraction of the backtest, with deep drawdowns and real tail risk (it holds short-volatility ETFs, which can halve in a day).

What a tradable version would look like

The idea — be aggressive in uptrends, defensive in downtrends — is sound. It’s the implementation that turns it into a backtest toy. A tradable version strips the toy parts:

1. Drop or cap the leverage. Trade QQQ/SPY at 1x, not TQQQ/SOXL at 3x. That removes the daily-rebalancing decay and the short-vol blow-up risk — and makes the result something you can actually scale.
2. Simplify the rules. One trend filter plus one risk-off switch, not four bots and thirty thresholds. The real edge is just the regime call; the rest is curve-fit.
3. Validate out-of-sample. Build the rules on 2008–2018, then test untouched on 2019–2025. If it survives that, it’s real. If it falls apart, it was fit to the bull.
4. Set honest expectations. Aim for ~15–25% annual return with 20–30% drawdowns. That’s a genuinely good, real trend/risk-on strategy — not 129% a year.

The bottom line

The backtest isn’t fake and the strategy isn’t worthless — but the headline is fantasy. It’s a faithful-but-unrealizable simulation of leveraged-tech beta with hindsight hedges and overfit thresholds, carrying a 63% drawdown and no proof it survives a real crisis. If a backtest turns $100k into billions, that’s the single strongest signal it won’t hold live. Strip out the leverage, the complexity and the hindsight, validate it on data it wasn’t built on, and you might have something you can actually trade — at a fraction of the returns, and all the more believable for it.

Methodology: a faithful port of the four-bot RSI/SMA rotation engine, run on real split/dividend-adjusted daily ETF prices (37 tickers, AV-sourced), 2013–2026, with whole-share rebalancing, commission and 0–50 bps slippage tested. Buy-and-hold QQQ as the control. Pre-2013 (dot-com, 2008) requires synthesizing the leveraged ETFs from their underlying indices — a separate acid test.